A complete application in a minute
Tailored resume and cover letter, ready to send.
Revolution Medicines is seeking a Head of Procurement to lead our enterprise procurement function, shaping strategy across R&D, Clinical, Manufacturing, Commercial, IT, and Corporate teams. You will evolve the procurement operating model, drive governance, and establish scalable supplier management programs to enable growth.
Reporting to the VP, Finance and Controller, you will partner with Compliance, Legal, and Information Security to manage third-party risk, optimize spend, and deliver value
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Reporting to the VP, Finance and Controller, the Head of Procurement will lead Revolution Medicines' enterprise procurement function, including procurement strategy, strategic sourcing, supplier management, procurement operations, governance, and transformation initiatives. This leader will be responsible for further maturing procurement as a scalable enterprise capability and trusted business partner that supports the company's continued growth across R&D, Clinical, Manufacturing, Commercial, IT, and Corporate functions.